UNSPSC 51333702: Licostinel
Commodity
Code facts
- Part of
-
-
51000000
-
51330000
- 51333700
-
51330000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51333702
Definition
This classification denotes a neuroprotective agent with the molecular formula C8H3Cl2N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z3037LJTC, chemically known as 6,7-dichloro-5-nitro-2,3-quinoxalinedione but generally known as licostinel, which bears US NIH Compound Identifier 5486198. European Medicines Agency schedules Licostinel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08503MIG.
Read the full definition
The term LICOSTINEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). LICOSTINEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule licostinel under HS 29339990 and SITC 51577. As of Q4 2014, LICOSTINEL remains the US FDA Preferred Term for this commodity. Licostinel bears US NLM identifiers UMLS ID C0294340 and NCI Concept Code C73248. SMILES: CLC1C([N](=O)O)C2[NH]C(=O)C(=O)[NH]C2CC1CL.
About UNSPSC 51333702
UNSPSC 51333702 Licostinel is a Commodity code that does not align with the recent state and local opportunities posted under it. The three most recent solicitations—from Seminole County, Florida (naloxone and drug deactivation systems), the Texas Health and Human Services Commission (direct-to-manufacturer prescription programs), and the Minnesota Multistate Cooperative Purchasing Alliance (generic multi-source pharmaceuticals and OTC products)—all involve pharmaceutical procurement, pharmaceutical benefit management, and naloxone distribution, but none address licostinel specifically. The mismatch between the code's nominal scope and the actual work being solicited suggests either a tagging error in the source data or that licostinel procurement does not currently appear in recent state and local contract activity.
The issuing bodies posting under this code span state health agencies (Texas HHS), county public health departments (Seminole County), and multistate cooperative purchasing alliances (MMCAP, administered through Minnesota). Recent activity clusters in Texas and Florida, with multistate reach through MMCAP's member jurisdictions including Oregon and Minnesota. The Seminole County IFB for naloxone and drug deactivation systems closed July 26, 2023; the Texas HHS RFI for direct-to-manufacturer prescriptions closed April 3, 2026; and the MMCAP RFP for generic pharmaceuticals closed March 26, 2026. Until licostinel-specific opportunities surface in state and local procurement records, the code shows no decision-relevant recent activity for pursuing.
Quick answers
What is UNSPSC 51333702?
UNSPSC 51333702 is Licostinel, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51333702?
UNSPSC 51333702 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51333702
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code